OCTAGON CAPITAL ADVISORS LP – Ambrx Biopharma Inc. Transaction History
OCTAGON CAPITAL ADVISORS LP portfolio value:
$0
portfolio value
OCTAGON CAPITAL ADVISORS LP quarter portfolio value change:
-59.25%
quarter
Ambrx Biopharma Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -122.8K shares | -325K | $1.08 | 0 |
| Q2 2022 | share | Decrease | -17.80% | -26.6K shares | -291K | $2.65 | 122.8K |
| Q1 2022 | share | Decrease | -55.65% | -187.46K shares | -2.42M | $4.12 | 149.4K |
| Q4 2021 | share | Decrease | -3.75% | -13.13K shares | -1.68M | $9 | 336.86K |
| Q3 2021 | share | Decrease | -22.22% | -100K shares | -4.09M | $13.5 | 350K |
| Q2 2021 | share | Increase | 0.00% | 450K shares | 8.82M | $19.6 | 450K |